Dendreon shares Left for Dead?
There are the crazy price targets such as $18 by Maxim Group set in September and more reasonable $7 from Baird back in August. Going with BofA would represent a 44% increase to get back to $6 from today's price. Take a look at the crack price tp of $18, a 300%+ increase in the next 12 months...really?
|Ticker||Current Price||Target Price||% Increase|
Dendreon reports Q3 earnings at the end of the month on October 30th. Expect the stock to tread water until we hear something at that time. What could work for playing the conference call is a covered call on DNDN to protect your neck.
MASTERY Bottom line:
Provenge has a bunch of competition and when it costs $100K per patient, its not going to everyone who could really benefit from it.
Medivation (MDVN) and Astellas Pharma (ALPMY.PK) are getting ready to take on Provenge with their prostate cancer fighting drug Xtandi. There is room in the prostate cancer arena, these drugs are used at different stages of treating prostate cancer. Johnson & Johnson's (JNJ) Zytiga is also competing in this space as is Jevtana from Sanofi. The prostate cancer treatment field is getting crowded, its why DNDN has tanked to $4.
However Dendreon isn't dead yet. The stock can go lower but at $4 its worth a few bucks to go long.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Japan Economy Minister: "Yen's Excessive Strength Has Been Largely Corrected; Further Weakness Could Be Harmful" | ZeroHedge
- Europe's EUR 500 Billion Ticking NPLTime Bomb | ZeroHedge
- Long-Term Breakout | Financial Sense
- Precious Metals Hit 3-Week Lows, ETFs “Could Sell Another 250 Tonnes of Gold” | Financial Sense
- It’s Official: Gold Is Now The Most Hated Asset Class | ZeroHedge
- Market Rally Continues Along With QE | ZeroHedge
- Guest Post: Why Bonds Aren't Dead & The Dollar Will Get Weaker | ZeroHedge
The most relevant financial news and articles from the Internets
- Unusual 11 Mid-... | StreetInsider.com
- 2012 Honda CR-V | BusinessWeek
- Watch The Trailer For The Scathing Drama Creating A Huge Buzz In China | Business Insider
- Market Wrap: Housing Starts Slump; S&P... | StreetInsider.com
- Satellite Images Show The Utter Precision Of Israel's Airstrike On Damascus... | Business Insider
- The Hilarious Things Passengers Say On Virgin Airlines | Business Insider
- Big Bank Phobia: Liquidity, Stupid, Not Just Capital | TheStreet.com